Drew Moghanaki: The PACIFIC-5 study results are finally available

Comparing SBRT to RFA for Hepatocellular Carcinoma

Treatment Selection for the High-risk Patient with Stage I NSCLC

Drew Moghanaki: An updated report from the MISSILE study team

Drew Moghanaki: The largest randomized phase III trial evaluating lung SBRT

Randomized comparison of SBRT vs RFA for recurrent small HCC

Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer

Radiation therapy vs Systemic therapy for Breast Cancer

One community at a time: Enabling early lung cancer detection across the U.S.

A thoracic surgeon is now the residency program director for UCLA General Surgery Residency Program